Biotech · Private company · Baltimore, MD, US
Kalocyte, Inc.
Track this companyFree. Adds Kalocyte, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- ErythroMer: Nanoscale BioSynthetic Red Cell SubstituteFiscal year 2025 · $995.5KNIH RePORTER 5R44HL135965-06 · fetched Nov 12, 2026
- ErythroMer: Nanoscale BioSynthetic Red Cell SubstituteFiscal year 2024 · $997.6KNIH RePORTER 5R44HL135965-05 · fetched Nov 12, 2026